Please Wait...

Andrew Masters

Translation skills

Main profile

Andrew Masters
Chief Technology Officer

Andrew has a pivotal role with Bioclinica as our Chief Technology Officer. Since joining Bioclinica in 2015, Andrew has successfully led the product development and technology services for Bioclinica's eHealth business. Among his many achievements, he has led the evolution of our existing product suite and transition to our next-generation cloud and patient-centered analytics platform. Prior to joining the Company, Andrew was vice president of global strategic innovation at PPD where he led new business model development for mobile, data simulation and other technologies including Preclarus™ award-winning analytics. With more than 20 years of industry experience, Andrew previously held technology and leadership roles with DHL Express, Avnet, MCI Worldcom, and Lenovo where he led the consolidation and retirement of 9,000 worldwide legacy applications and related business processes. Andrew, who has an MBA from Duke University, began his technology career with the U.S. Navy in Naval research.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Bioclinica Delivers Individual Case Safety Report (ICSR) Processing w Quality & Consistency While Crossing One Mil… https://t.co/77NOME2Dj7
bioclinica (21 hours ago)
Who made the BioSpace list of 11 most innovative life sciences companies in the world? Ck it out here via @biospace… https://t.co/f9vtRpsbMW
bioclinica (Yesterday)
BREAKING: With a passion for Drug Safety, we’re delighted to share @bioclinica #pharmacovigilance crossed 1M ICSR c… https://t.co/PAdROjo7tE
bioclinica (Yesterday)
RT @isciencebox: Draft and Final FDA Guidances Detail Development of New Drugs for Neurological Disorders @RAPSorg https://t.co/cAewLypUY7
bioclinica (2 days ago)
RT @RAPSorg: Final @US_FDA Rule Requires Medical Device Trials Outside US to Conform to GCP | #Regulatory Focus https://t.co/jgwaqxfiXl #FD…
bioclinica (2 days ago)
Congrats @bioclinica on @Clin_Info_News Best Practices Award 4 "Transformational Med. Imaging in #ClinicalTrials. '… https://t.co/NxauNywq23
bioclinica (6 days ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen